Journal: Frontiers in Cardiovascular Medicine
Article Title: NF- κ B aggravates cardiac vascular endothelial injury by sustained activation of the NLRP3 inflammasome after ischemic stroke in rats
doi: 10.3389/fcvm.2026.1673693
Figure Lengend Snippet: The formation of the NLRP3 inflammasome induced the activation of ECs in the heart after dMCAO. (A) Western blotting shows the expression of NLRP3, ASC, and Casp-1 in vessels of the heart in the Sham and dMCAO animals. (B–D) Quantitative analysis of NLRP3, ASC, and Casp-1 levels relative to GAPDH. Each bar represents the mean ± SD. * p < 0.05 vs. Sham group ( n = 4 in each group). (E) Double-immunofluorescence staining of NLRP3 (green) with RECA-1 (red) in vessels of the heart in Sham or dMCAO 2 w rats injected with Veh or MCC950. Immunofluorescence staining of CD45 in the heart in Sham or dMCAO 2 w rats injected with Veh or MCC950. Scale bar: 25 μm. (F) The degree of overlap between NLRP3 and RECA-1 fluorescence based on the Pearson correlation coefficient in each group. (G) Quantitative analysis of CD45 + cells in each group. (H) Western blotting shows the expression of NLRP3, ASC, Casp-1, VCAM-1, ICAM-1, IL-1β, and TNF-α in vessels of the heart in the Sham and dMCAO rats injected with Veh or MCC950. (I–O) Quantitative analysis of NLRP3, ASC, Casp-1, VCAM-1, ICAM-1, IL-1β, and TNF-α levels relative to GAPDH. Each bar represents the mean ± SD. * p < 0.05 vs. Sham group, # p < 0.05 vs. dMCAO 2 w + Veh group ( n = 4 in each group). Sham, sham operation; dMCAO, distal middle cerebral artery occlusion; NLRP3, NOD-like receptor thermal protein domain associated protein 3; ASC, apoptosis-associated speck-like protein containing a CARD; Casp-1, caspase-1; Veh, Vehicle; RECA-1, rat endothelial cell antibody 1; VCAM-1, vascular cell adhesion molecule 1; ICAM-1, intercellular cell adhesion molecule-1; IL-1β, interleukin-1 beta; TNF-α, tumor necrosis factor-alpha; w, week.
Article Snippet: The NLRP3-selective inflammasome inhibitor MCC950 (MedChemExpress, HY-12815A), the NF- κ B p65 inhibitor PDTC (MedChemExpress, HY-18738), or the vehicle (normal saline, NS) was injected intraperitoneally 24 h before dMCAO.
Techniques: Activation Assay, Western Blot, Expressing, Double Immunofluorescence Staining, Injection, Immunofluorescence, Staining, Fluorescence